Cargando…
The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
Malignant pleural effusion (MPE) is a severe medical condition, which can result in breathlessness, pain, cachexia and reduced physical activity. It can occur in almost all types of malignant tumors; however, lung cancer is the most common cause of MPE, accounting for ~1/3 of clinical cases. Althoug...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983970/ https://www.ncbi.nlm.nih.gov/pubmed/29693703 http://dx.doi.org/10.3892/mmr.2018.8922 |
_version_ | 1783328536077008896 |
---|---|
author | Chen, Yao Mathy, Nicholas W. Lu, Hongda |
author_facet | Chen, Yao Mathy, Nicholas W. Lu, Hongda |
author_sort | Chen, Yao |
collection | PubMed |
description | Malignant pleural effusion (MPE) is a severe medical condition, which can result in breathlessness, pain, cachexia and reduced physical activity. It can occur in almost all types of malignant tumors; however, lung cancer is the most common cause of MPE, accounting for ~1/3 of clinical cases. Although there are numerous therapeutic approaches currently available for the treatment of MPE, none are fully effective and the majority can only alleviate the symptoms of the patients. Vascular endothelial growth factor (VEGF) has now been recognized as one of the most important regulatory factors in tumor angiogenesis, which participates in the entire process of tumor growth through its function to stimulate tumor angiogenesis, activate host vascular endothelial cells and promote malignant proliferation. Novel drugs targeting VEGF, including endostar and bevacizumab, have been developed and approved for the treatment of various tumors. Data from recent clinical studies have demonstrated that drugs targeting VEGF are effective and safe for the clinical management of MPE. Therefore, VEGF-targeting represents a promising novel strategy for the diagnosis and treatment of MPE. The present review summarized recent advances in the role of VEGF in the pathogenesis, diagnosis and clinical management of MPE in patients with non-small cell lung cancer. |
format | Online Article Text |
id | pubmed-5983970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-59839702018-06-04 The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer Chen, Yao Mathy, Nicholas W. Lu, Hongda Mol Med Rep Review Malignant pleural effusion (MPE) is a severe medical condition, which can result in breathlessness, pain, cachexia and reduced physical activity. It can occur in almost all types of malignant tumors; however, lung cancer is the most common cause of MPE, accounting for ~1/3 of clinical cases. Although there are numerous therapeutic approaches currently available for the treatment of MPE, none are fully effective and the majority can only alleviate the symptoms of the patients. Vascular endothelial growth factor (VEGF) has now been recognized as one of the most important regulatory factors in tumor angiogenesis, which participates in the entire process of tumor growth through its function to stimulate tumor angiogenesis, activate host vascular endothelial cells and promote malignant proliferation. Novel drugs targeting VEGF, including endostar and bevacizumab, have been developed and approved for the treatment of various tumors. Data from recent clinical studies have demonstrated that drugs targeting VEGF are effective and safe for the clinical management of MPE. Therefore, VEGF-targeting represents a promising novel strategy for the diagnosis and treatment of MPE. The present review summarized recent advances in the role of VEGF in the pathogenesis, diagnosis and clinical management of MPE in patients with non-small cell lung cancer. D.A. Spandidos 2018-06 2018-04-23 /pmc/articles/PMC5983970/ /pubmed/29693703 http://dx.doi.org/10.3892/mmr.2018.8922 Text en Copyright: © Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Chen, Yao Mathy, Nicholas W. Lu, Hongda The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
title | The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
title_full | The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
title_fullStr | The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
title_full_unstemmed | The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
title_short | The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
title_sort | role of vegf in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983970/ https://www.ncbi.nlm.nih.gov/pubmed/29693703 http://dx.doi.org/10.3892/mmr.2018.8922 |
work_keys_str_mv | AT chenyao theroleofvegfinthediagnosisandtreatmentofmalignantpleuraleffusioninpatientswithnonsmallcelllungcancer AT mathynicholasw theroleofvegfinthediagnosisandtreatmentofmalignantpleuraleffusioninpatientswithnonsmallcelllungcancer AT luhongda theroleofvegfinthediagnosisandtreatmentofmalignantpleuraleffusioninpatientswithnonsmallcelllungcancer AT chenyao roleofvegfinthediagnosisandtreatmentofmalignantpleuraleffusioninpatientswithnonsmallcelllungcancer AT mathynicholasw roleofvegfinthediagnosisandtreatmentofmalignantpleuraleffusioninpatientswithnonsmallcelllungcancer AT luhongda roleofvegfinthediagnosisandtreatmentofmalignantpleuraleffusioninpatientswithnonsmallcelllungcancer |